Flaherty KR, King TE, Jr., Raghu G, Lynch JP, 3rd, Colby TV, Travis WD, et al. Idiopathic interstitial pneumonia: what is the effect of a multidisciplinary approach to diagnosis? Am J Respir Crit Care Med. 2004;170(8):904–10.
Greer HO, Frederick PJ, Falls NM, Tapley EB, Samples KL, Kimball KJ, et al. Impact of a weekly multidisciplinary tumor board conference on the management of women with gynecologic malignancies. Int J Gynecol Cancer. 2010;20(8):1321–5.
Vancheri C, Failla M, Crimi N, Raghu G. Idiopathic pulmonary fibrosis: a disease with similarities and links to cancer biology. Eur Respir J. 2010;35(3):496–504.
Richeldi L, du Bois RM, Raghu G, Azuma A, Brown KK, Costabel U, et al. Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2071–82.
Travis WD, Costabel U, Hansell DM, King TE, Jr., Lynch DA, Nicholson AG, et al. An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med. 2013;188(6):733–48.
Theegarten D, Muller HM, Bonella F, Wohlschlaeger J, Costabel U. Diagnostic approach to interstitial pneumonias in a single centre: report on 88 cases. Diagn Pathol. 2012;7:160.
Tomassetti S, Piciucchi S, Tantalocco P, Dubini A, Poletti V. The multidisciplinary approach in the diagnosis of idiopathic pulmonary fibrosis: a patient case-based review. Eur Respir Rev. 2015;24(135):69–77.
Roche N, Reddel H, Martin R, Brusselle G, Papi A, Thomas M, et al. Quality standards for real-world research. Focus on observational database studies of comparative effectiveness. Ann Am Thorac Soc. 2014;11(Suppl 2):S99–104.
Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, et al. An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med. 2011;183(6):788–824.
Idiopathic Pulmonary Fibrosis Clinical Research N, Raghu G, Anstrom KJ, King TE, Jr., Lasky JA, Martinez FJ. Prednisone, azathioprine, and N-acetylcysteine for pulmonary fibrosis. N Engl J Med. 2012;366(21):1968–77.
King TE, Jr., Bradford WZ, Castro-Bernardini S, Fagan EA, Glaspole I, Glassberg MK, et al. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. N Engl J Med. 2014;370(22):2083–92.
Elicker BM, Jones KD, Henry TS, Collard HR. Multidisciplinary Approach to Hypersensitivity Pneumonitis. J Thorac Imaging. 2016;31(2):92–103.
Daniel P. Franzen,
Martin Brutsche,
Jakob Nilsson,
Christian Böni,
Cécile Daccord,
Oliver Distler,
Dieter Elsener,
Manuela Funke-Chambour,
Christiane Gruner,
Helen Hayward-Könnecke,
Katrin E. Hostettler,
Thomas Kündig,
Camillo Ribi,
Jörg D. Seebach,
Harald Seeger,
Bart Vrugt,
Antonios G. A. Kolios,
Sarcoidosis – a multisystem disease
,
Swiss Medical Weekly: Vol. 152 No. 0102 (2022)
Lisa Jungblut,
Christophe von Garnier,
Milo Puhan,
Yuki Tomonaga,
Cornel Kaufmann,
Andrea Azzola,
Urs Bürgi,
Jens Bremerich,
Martin Brutsche,
Andreas Christe,
Lukas Ebner,
Johannes T Heverhagen,
Christine Eich,
Daniel Franzen,
Isabelle Schmitt-Opitz,
Didier Schneiter,
Jörg Spieldenner,
Nigel Horwarth,
Malcolm Kohler,
Walter Weder,
Alban Lovis,
Reto Meuli,
Matthias Menig,
Catherine Beigelmann-Aubry,
Tilo Niemann,
Susanna Stöhr,
Peter Vock,
Oliver Senn,
Stefan Neuner-Jehle,
Kevin Selby,
Simin Laures,
Sebastian Ott,
Thomas Frauenfelder,
The Swiss Approach – feasibility of a national low-dose CT lung cancer screening program
,
Swiss Medical Weekly: Vol. 152 No. 1516 (2022)
